Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Tildrakizumab
Trade Name Ilumya
Synonyms MK-3222
Drug Descriptions

Ilumya (tildrakizumab) is a monoclonal antibody that binds to the p19 subunit of IL-23 and prevents interaction with the IL-23 receptor, potentially leading to decreased release of proinflammatory cytokines (PMID: 31548750). Ilumya (tildrakizumab) is FDA approved for use in patients with moderate-to-severe plaque psoriasis (FDA.gov).

DrugClasses
CAS Registry Number 1326244-10-3
NCIT ID C152627

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Abiraterone + Tildrakizumab Abiraterone Tildrakizumab 0 1
Tildrakizumab Tildrakizumab 0 0


Additional content available in CKB BOOST